NCT01234454View on ClinicalTrials.gov

Atypical Antipsychotic Treatment Effect On Brain Function In Schizophrenia Measured By FMRI

NACompletedINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

January 31, 2002

Primary Completion Date

June 30, 2005

Study Completion Date

December 31, 2007

Conditions
Schizophrenia
Interventions
DRUG

Risperidone

6mg/day or highest dose tolerated for 8 weeks, following 4 weeks baseline treatment of Thiothixene

DRUG

Olanzapine

20mg/day for 8 weeks, following 4 weeks of baseline Thiothixene.

Trial Locations (1)

27599

Unc Psychiatry, Chapel Hill

All Listed Sponsors
lead

University of North Carolina, Chapel Hill

OTHER

NCT01234454 - Atypical Antipsychotic Treatment Effect On Brain Function In Schizophrenia Measured By FMRI | Biotech Hunter | Biotech Hunter